Here are eight updates from gastroenterology companies and practices from the past week:
Gastroenterology Associates' two outpatient endoscopy centers — Endoscopy Center of Niagara and Endoscopy Center of Western New York — made ownership changes involving non-physician owners.
The majority of Medicare patients were likely to complete the multitarget stool DNA test Cologuard over a yearlong period. Read more.
Fujifilm Europe launched its real-time colonic polyp detection tool Cad Eye in Europe after receiving a CE mark.
Perardi Development is building a medical office building in Austin, Texas, which a gastroenterology-facing tenant is expected to lease space in.
Johnson & Johnson affiliate Janssen is accused of providing free business advisory services to grow gastroenterology practices' infusion suites, which would then boost prescriptions of two Janssen drugs, according to a lawsuit filed in the U.S. District Court for the District of Massachusetts.
Miami-based Gastro Health made a trio of acquisitions, including the group's second acquisition in Virginia, to kick off 2020.
The Center for Advanced Medicine & Surgery at White Plains Hospital will expand its gastroenterology offerings in 2021, along with a handful of other services.
The FDA approved Olympus' TJF-Q190V duodenoscope, which notably features a sterile, disposable distal endcap.